8-K 1 a4501126.txt VENTANA MEDICAL SYSTEMS 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ------------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 24, 2003 Date of Report (date of earliest event reported) ------------------------------------- VENTANA MEDICAL SYSTEMS, INC. (Exact name of Registrant as specified in its charter) State of Delaware 000-20931 94-2976937 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation or organization) Identification Number) 1910 Innovation Park Drive Tucson, AZ 85737 (Address of principal executive offices) (520) 887-2155 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) ----------------------------------------------------------------------- Item 7. Financial Statements and Exhibits (c) Exhibits Exhibit No. Description ---------------- --------------------------------------------------------------- 99.1 Press Release, dated as of October 24, 2003 Item 9. Regulation FD Disclosure (pursuant to Item 12) In accordance with Securities and Exchange Commission Release No. 33-8216, the following information, which is intended to be furnished under Item 12, "Results of Operations and Financial Condition," is instead being furnished under Item 9, "Regulation FD Disclosure." This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On October 24, 2003, Ventana Medical Systems, Inc. ("Ventana") issued a press release regarding Ventana's results of operations for the quarter ended September 30, 2003, and disclosing material non-public information. The press release is attached hereto as Exhibits 99.1 and is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. VENTANA MEDICAL SYSTEMS, INC. By: / s / NICHOLAS MALDEN -------------------------------------------- Nicholas Malden Vice President, Chief Financial Officer and Secretary Date: October 24, 2003 EXHIBIT INDEX Exhibit Description 99.1 Press release issued by Ventana Medical Systems, Inc. dated October 24, 2003.